Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 7

TABLE OF CONTENTS Volume 37, Issue 7 (June 2012) In this issue Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Neuropsychopharmacology Reviews Highlighting Neurotherapeutics in 2012 Published each January as a special issue of Neuropsychopharmacology, the 2012 edition highlights Neurotherapeutics, with a thorough look at hot topics in this area and in-depth review articles. Visit www.neuropsychopharmacologyreviews.org and gain access to the full list of reviews.   Original Articles Top Differential Effects of Cocaine on Dopamine Neuron Firing in Awake and Anesthetized Rats Stanislav Koulchitsky, Benjamin De Backer, Etienne Quertemont, Corinne Charlier and Vincent Seutin Neuropsychopharmacology 2012 37: 1559-1571; advance online publication, February 1, 2012; 10.1038/npp.2011.339 Abstract | Full Text Evidence of IQ-Modulated Association Between ZNF804A Gene Polymorphism and Cognitive Function in Schizophrenia Patients Min Chen, Zhansheng Xu, Jinguo Zhai, Xin Bao, Qiumei Zhang, Huang Gu, Qiuge Shen, Lina Cheng, Xiongying Chen, Keqin Wang, Xiaoxiang Deng, Feng Ji, Chuanxin Liu, Jun Li, Qi Dong and Chuansheng Chen Neuropsychopharmacology 2012 37: 1572-1578; advance online publication, February 29, 2012; 10.1038/npp.2012.1 Abstract | Full Text Loss of Environmental Enrichment Increases Vulnerability to Cocaine Addiction Joëlle Nader, Chauvet Claudia, Rana El Rawas, Laure Favot, Mohamed Jaber, Nathalie Thiriet and Marcello Solinas Neuropsychopharmacology 2012 37: 1579-1587; advance online publication, February 15, 2012; 10.1038/npp.2012.2 Abstract | Full Text Prevention of Stress-Impaired Fear Extinction Through Neuropeptide S Action in the Lateral Amygdala Frédéric Chauveau, Maren Denise Lange, Kay Jüngling, Jörg Lesting, Thomas Seidenbecher and Hans-Christian Pape Neuropsychopharmacology 2012 37: 1588-1599; advance online publication, February 1, 2012; 10.1038/npp.2012.3 Abstract | Full Text Physical Exercise and Antidepressants Enhance BDNF Targeting in Hippocampal CA3 Dendrites: Further Evidence of a Spatial Code for BDNF Splice Variants Gabriele Baj, Valentina D'Alessandro, Laura Musazzi, Alessandra Mallei, Cesar R Sartori, Marina Sciancalepore, Daniela Tardito, Francesco Langone, Maurizio Popoli and Enrico Tongiorgi Neuropsychopharmacology 2012 37: 1600-1611; advance online publication, February 8, 2012; 10.1038/npp.2012.5 Abstract | Full Text Drug Intake is Sufficient, but Conditioning is not Necessary for the Emergence of Compulsive Cocaine Seeking After Extended Self-Administration Sietse Jonkman, Yann Pelloux and Barry J Everitt Neuropsychopharmacology 2012 37: 1612-1619; advance online publication, February 15, 2012; 10.1038/npp.2012.6 Abstract | Full Text Olanzapine, but Not Fluoxetine, Treatment Increases Survival in Activity-Based Anorexia in Mice Stephanie J Klenotich, Mariel P Seiglie, Matthew S McMurray, Jamie D Roitman, Daniel Le Grange, Priya Dugad and Stephanie C Dulawa Neuropsychopharmacology 2012 37: 1620-1631; advance online publication, March 7, 2012; 10.1038/npp.2012.7 Abstract | Full Text Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in Humans Deepak Cyril D'Souza, Daniel J Fridberg, Patrick D Skosnik, Ashley Williams, Brian Roach, Nagendra Singh, Michelle Carbuto, Jacqueline Elander, Ashley Schnakenberg, Brian Pittman, R Andrew Sewell, Mohini Ranganathan and Daniel Mathalon Neuropsychopharmacology 2012 37: 1632-1646; advance online publication, February 15, 2012; 10.1038/npp.2012.8 Abstract | Full Text Selective DNA Methylation of BDNF Promoter in Bipolar Disorder: Differences Among Patients with BDI and BDII Claudio D'Addario, Bernardo Dell'Osso, Maria Carlotta Palazzo, Beatrice Benatti, Licia Lietti, Elisabetta Cattaneo, Daniela Galimberti, Chiara Fenoglio, Francesca Cortini, Elio Scarpini, Beatrice Arosio, Andrea Di Francesco, Manuela Di Benedetto, Patrizia Romualdi, Sanzio Candeletti, Daniela Mari, Luigi Bergamaschini, Nereo Bresolin, Mauro Maccarrone and A Carlo Altamura Neuropsychopharmacology 2012 37: 1647-1655; advance online publication, February 22, 2012; 10.1038/npp.2012.10 Abstract | Full Text Chronic Corticosterone Exposure during Adolescence Reduces Impulsive Action but Increases Impulsive Choice and Sensitivity to Yohimbine in Male Sprague-Dawley Rats Mary M Torregrossa, Maylene Xie and Jane R Taylor Neuropsychopharmacology 2012 37: 1656-1670; advance online publication, February 15, 2012; 10.1038/npp.2012.11 Abstract | Full Text Temporally Dependent Changes in Cocaine-Induced Synaptic Plasticity in the Nucleus Accumbens Shell are Reversed by D1-Like Dopamine Receptor Stimulation Pavel I Ortinski, Fair M Vassoler, Gregory C Carlson and R Christopher Pierce Neuropsychopharmacology 2012 37: 1671-1682; advance online publication, March 14, 2012; 10.1038/npp.2012.12 Abstract | Full Text Pharmacogenetic Association of the Galanin Receptor (GALR1) SNP rs2717162 with Smoking Cessation Allison B Gold, E Paul Wileyto, Adriana Lori, David Conti, Joseph F Cubells and Caryn Lerman Neuropsychopharmacology 2012 37: 1683-1688; advance online publication, February 29, 2012; 10.1038/npp.2012.13 Abstract | Full Text A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults Barbara J Mason, Rebecca Crean, Vivian Goodell, John M Light, Susan Quello, Farhad Shadan, Kimberly Buffkins, Mark Kyle, Murali Adusumalli, Adnan Begovic and Santosh Rao Neuropsychopharmacology 2012 37: 1689-1698; advance online publication, February 29, 2012; 10.1038/npp.2012.14 Abstract | Full Text Dissociation of Hedonic Reaction to Reward and Incentive Motivation in an Animal Model of the Negative Symptoms of Schizophrenia Ryan D Ward, Eleanor H Simpson, Vanessa L Richards, Gita Deo, Kathleen Taylor, John I Glendinning, Eric R Kandel and Peter D Balsam Neuropsychopharmacology 2012 37: 1699-1707; advance online publication, March 14, 2012; 10.1038/npp.2012.15 Abstract | Full Text Cocaine Self-Administration Produces Pharmacodynamic Tolerance: Differential Effects on the Potency of Dopamine Transporter Blockers, Releasers, and Methylphenidate Mark J Ferris, Erin S Calipari, Yolanda Mateo, James R Melchior, David CS Roberts and Sara R Jones Neuropsychopharmacology 2012 37: 1708-1716; advance online publication, March 7, 2012; 10.1038/npp.2012.17 Abstract | Full Text Effects of Sustained Administration of Quetiapine Alone and in Combination with a Serotonin Reuptake Inhibitor on Norepinephrine and Serotonin Transmission Olga Chernoloz, Mostafa El Mansari and Pierre Blier Neuropsychopharmacology 2012 37: 1717-1728; advance online publication, February 29, 2012; 10.1038/npp.2012.18 Abstract | Full Text Dopamine Modulates Reward System Activity During Subconscious Processing of Sexual Stimuli Nicole Y L Oei, Serge ARB Rombouts, Roelof P Soeter, Joop M van Gerven and Stephanie Both Neuropsychopharmacology 2012 37: 1729-1737; advance online publication, March 7, 2012; 10.1038/npp.2012.19 Abstract | Full Text A Single Administration of Low-Dose Varenicline Saturates α4β2* Nicotinic Acetylcholine Receptors in the Human Brain Shahrdad Lotfipour, Mark Mandelkern, Miguel Alvarez-Estrada and Arthur L Brody Neuropsychopharmacology 2012 37: 1738-1748; advance online publication, March 7, 2012; 10.1038/npp.2012.20 Abstract | Full Text Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors Auxiliadora Aracil-Fernández, José M Trigo, María S García-Gutiérrez, Antonio Ortega-Álvaro, Alexander Ternianov, Daniela Navarro, Patricia Robledo, Pere Berbel, Rafael Maldonado and Jorge Manzanares Neuropsychopharmacology 2012 37: 1749-1763; advance online publication, March 14, 2012; 10.1038/npp.2012.22 Abstract | Full Text Frontal Theta Cordance Predicts 6-Month Antidepressant Response to Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression: A Pilot Study James M Broadway, Paul E Holtzheimer, Matthew R Hilimire, Nathan A Parks, Jordan E DeVylder, Helen S Mayberg and Paul M Corballis Neuropsychopharmacology 2012 37: 1764-1772; advance online publication, March 14, 2012; 10.1038/npp.2012.23 Abstract | Full Text Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic Pathways Áine T Behan, Magdalena Hryniewiecka, Colm M P O'Tuathaigh, Anthony Kinsella, Mary Cannon, Maria Karayiorgou, Joseph A Gogos, John L Waddington and David R Cotter Neuropsychopharmacology 2012 37: 1773-1783; advance online publication, March 21, 2012; 10.1038/npp.2012.24 Abstract | Full Text Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease Giuseppe D'Agostino, Roberto Russo, Carmen Avagliano, Claudia Cristiano, Rosaria Meli and Antonio Calignano Neuropsychopharmacology 2012 37: 1784-1792; advance online publication, March 14, 2012; 10.1038/npp.2012.25 Abstract | Full Text Corrigendum Top Behavioral and Neural Analysis of GABA in the Acquisition, Consolidation, Reconsolidation, and Extinction of Fear Memory Steve R Makkar, Shirley Q Zhang and Jacquelyn Cranney Neuropsychopharmacology 2012 37: 1793-1794; 10.1038/npp.2012.16 Full Text Advertisement Neuropsychopharmacology Brainpod: Neurotherapeutics The brain is a daunting therapeutic challenge. This year's edition of Neuropsychopharmacology Reviews provides an update on treatments for brain disorders ranging from schizophrenia to neurodegeneration. Join Kerri Smith as she talks to Gwenn Smith, editor of this year's volume, about current therapies such as drugs, electrical stimulation and cognitive therapies, and the future of neurotherapeutics in an era of uncertain funding. Visit www.nature.com/npp/podcast   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.